Product Information
QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.1285 per EA under NDC 68001018303. Its NADAC has been published 638 times since Jun 4, 2014.
FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001018303
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA201109FDA Approved
3/27/2012
TE Code
AB
On Market Since
2/28/2013
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 638 times since Jun 4, 2014, and over the history we have for it it has declined 69.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1285 per EA |
|---|---|
| All-time high | $0.4513 (Nov 12, 2014) |
| All-time low | $0.1136 (Nov 20, 2024) |
| 52-week high | $0.1465 |
| 52-week low | $0.1265 |
| Median price | $0.1759 |
| Average price | $0.2152 |
| Largest weekly change | -26.7% (Nov 20, 2024) |
| Weeks tracked | 638 |
| Tracking since | Jun 4, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by BluePoint Laboratories, is $0.1285 per EA (NDC 68001018303), effective Aug 19, 2026.
How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?
Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 69.7%. It has been tracked across 638 weekly CMS publications since Jun 4, 2014.
What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?
Since Jun 4, 2014, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1136 (Nov 20, 2024) to a high of $0.4513 (Nov 12, 2014), with a median of $0.1759 per EA.
Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QUETIAPINE FUMARATE 300 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures QUETIAPINE FUMARATE 300 MG TAB?
QUETIAPINE FUMARATE 300 MG TAB (NDC 68001018303) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.